US Patent 9950046 Methods of treatment using alpha-1-antitrypsin compositions
Patent 9950046 was granted and assigned to CSL Behring on April, 2018 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 18, 2016
Date of Patent
April 24, 2018
Patent Applicant
Patent Application Number
15074266
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9950046 Methods of treatment using alpha-1-antitrypsin compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.